143 related articles for article (PubMed ID: 34335918)
1. Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells.
Iijima K; Nakamura H; Takada K; Hayasaka N; Kubo T; Umeyama Y; Iyama S; Miyanishi K; Kobune M; Kato J
Oncol Lett; 2021 Jul; 22(1):546. PubMed ID: 34335918
[TBL] [Abstract][Full Text] [Related]
2. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.
Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J
Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787
[TBL] [Abstract][Full Text] [Related]
3. Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.
Nakamura H; Takada K; Arihara Y; Hayasaka N; Murase K; Iyama S; Kobune M; Miyanishi K; Kato J
Cancer Gene Ther; 2019 Sep; 26(9-10):313-322. PubMed ID: 30401882
[TBL] [Abstract][Full Text] [Related]
4. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.
Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J
J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206
[TBL] [Abstract][Full Text] [Related]
5. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens.
Gomes IM; Rocha SM; Gaspar C; Alvelos MI; Santos CR; Socorro S; Maia CJ
Med Oncol; 2018 Feb; 35(3):40. PubMed ID: 29464393
[TBL] [Abstract][Full Text] [Related]
7. STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Xu M; Evans L; Bizzaro CL; Quaglia F; Verrillo CE; Li L; Stieglmaier J; Schiewer MJ; Languino LR; Kelly WK
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011027
[TBL] [Abstract][Full Text] [Related]
8. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Jin Y; Lorvik KB; Jin Y; Beck C; Sike A; Persiconi I; Kvaløy E; Saatcioglu F; Dunn C; Kyte JA
Mol Ther Oncolytics; 2022 Sep; 26():189-206. PubMed ID: 35860008
[TBL] [Abstract][Full Text] [Related]
9. Targeting STEAP1 as an anticancer strategy.
Nakamura H; Arihara Y; Takada K
Front Oncol; 2023; 13():1285661. PubMed ID: 37909017
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells.
Rocha SM; Santos FM; Socorro S; Passarinha LA; Maia CJ
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119522. PubMed ID: 37315586
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer.
Liu T; Niu X; Li Y; Xu Z; Chen J; Xu G
World J Surg Oncol; 2022 Mar; 20(1):96. PubMed ID: 35346237
[TBL] [Abstract][Full Text] [Related]
12. Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1).
Oosterheert W; Gros P
J Biol Chem; 2020 Jul; 295(28):9502-9512. PubMed ID: 32409586
[TBL] [Abstract][Full Text] [Related]
13. Promoter Demethylation Upregulates
Rocha SM; Sousa I; Gomes IM; Arinto P; Costa-Pinheiro P; Coutinho E; Santos CR; Jerónimo C; Lemos MC; Passarinha LA; Socorro S; Maia CJ
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833128
[TBL] [Abstract][Full Text] [Related]
14. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
15. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
16.
Wu YY; Jiang JN; Fang XD; Ji FJ
Front Physiol; 2018; 9():1132. PubMed ID: 30246786
[TBL] [Abstract][Full Text] [Related]
17. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells.
Gomes IM; Santos CR; Socorro S; Maia CJ
Prostate; 2013 May; 73(6):605-13. PubMed ID: 23060075
[TBL] [Abstract][Full Text] [Related]
18. Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis.
Zhao S; Chen H; Zhou Y; Wang Q; Liang X; Yang N; Yan L; Yang J
Front Biosci (Landmark Ed); 2023 Nov; 28(11):280. PubMed ID: 38062846
[TBL] [Abstract][Full Text] [Related]
19. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.
Guo L; Xie H; Zhang Z; Wang Z; Peng S; Niu Y; Shang Z
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358202
[TBL] [Abstract][Full Text] [Related]
20. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
Maia CJ; Socorro S; Schmitt F; Santos CR
Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
